GO:0005793 endoplasmic reticulum-Golgi intermediate compartment: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005793 describes the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), a membrane-bounded sorting station located between the ER and the Golgi complex.
• The ERGIC was originally defined as a vesicular-tubular cluster (VTC) with a distinctive membrane protein composition that mediates bidirectional ER-to-Golgi and Golgi-to-ER transport.
• ERGIC-resident proteins such as LMAN1 (ERGIC-53) and ERGIC-3 serve as experimental markers and functional effectors of this compartment.
• The ERGIC is increasingly recognized as a signaling hub, including a role in STING trafficking that links it to innate immune and autophagy pathways.
• Disease-associated factors at the ER-Golgi interface connect ERGIC biology to cancer, neurodegeneration and lysosomal dysfunction.
• CRISPR knockout, knock-in, point-mutation and overexpression models enable causal testing of ERGIC gene function in human cells.
Description
The endoplasmic reticulum-Golgi intermediate compartment (ERGIC), annotated as GO:0005793, is a complex system of membrane-bounded compartments positioned between the endoplasmic reticulum (ER) and the Golgi complex. It was initially identified as a vesicular-tubular cluster (VTC) that contains a distinctive set of membrane proteins and operates as the first sorting station on the secretory pathway. Because the ERGIC sits at the intersection of biosynthetic and retrieval traffic, it is central to how cells distribute proteins and lipids between the ER and the Golgi. The compartment is also a dynamic signaling platform: STING trafficking through the ERGIC is required for autophagy induction downstream of cGAS, showing that this organelle participates directly in innate immune responses. Disease-associated factors at the ER-Golgi interface further highlight the ERGIC as a node where secretory dysfunction can translate into pathology. For researchers, GO:0005793 therefore provides a precise ontological anchor for studying membrane traffic, organelle identity and stress signaling in human cells.
endoplasmic reticulum-Golgi intermediate compartment At A Glance
| GO ID | GO:0005793 |
|---|---|
| GO term | endoplasmic reticulum-Golgi intermediate compartment |
| Ontology | cellular_component |
| Synonym | ERGIC; ER-Golgi intermediate compartment; pre-Golgi intermediate compartment; vesicular-tubular cluster (VTC); ER-Golgi transport container; EGTC |
| Major function | ER-to-Golgi and Golgi-to-ER transport; cargo sorting and concentration between the ER and the Golgi complex |
| Marker proteins | LMAN1 (ERGIC-53) and ERGIC-3 are widely used ERGIC markers |
| Signaling role | Serves as a trafficking platform for STING and autophagy induction |
| Disease relevance | Linked to cancer, neurodegeneration and lysosomal dysfunction through ER-Golgi interface factors |
| Research methods | Imaging, proteomics, binding assays and CRISPR-based perturbation of ERGIC genes |
What Is GO:0005793?
In our own words, GO:0005793 refers to the collection of membrane-bounded compartments that lie between the ER and the Golgi complex and that have a characteristic membrane protein composition. These compartments are not a single static organelle but a complex system that receives cargo from the ER and sorts it for delivery to the Golgi, while also mediating Golgi-to-ER retrieval. The term is synonymous with ERGIC, ER-Golgi intermediate compartment, pre-Golgi intermediate compartment, vesicular-tubular cluster (VTC), ER-Golgi transport container and EGTC. Functionally, the ERGIC is defined by its position, its distinctive protein markers and its role in bidirectional ER-Golgi transport.
Why Is endoplasmic reticulum-Golgi intermediate compartment Important in Cell Biology?
The ERGIC is important because it is the first sorting station of the secretory pathway and therefore controls the fidelity of protein and lipid delivery between the ER and the Golgi. Defects in this compartment can perturb secretion, membrane homeostasis and stress responses, and disease-associated factors at the ER-Golgi interface have been linked to cancer and neurodegeneration. Beyond trafficking, the ERGIC has emerged as a signaling hub: STING must transit this compartment to trigger autophagy, connecting GO:0005793 to innate immunity. In addition, ERGIC protein 3 (ERGIC-3) knockdown suppresses lung cancer through ER stress-induced autophagy, demonstrating that ERGIC components can be functionally causal in tumor biology. Lysosomal proteomics in APOE4-associated neuronal dysfunction further implicates ER-Golgi interface mechanisms in neurodegeneration. Together, these findings make GO:0005793 a high-value term for both cell biology and translational research.
• Defines the first sorting station of the secretory pathway between the ER and the Golgi complex.
• Controls bidirectional ER-to-Golgi and Golgi-to-ER transport of proteins and lipids.
• Provides widely used marker proteins such as LMAN1 (ERGIC-53) and ERGIC-3 for organelle identification.
• Functions as a signaling platform for STING trafficking and autophagy induction.
• Is implicated in cancer through ERGIC-3-dependent ER stress and autophagy.
• Is connected to neurodegeneration via ER-Golgi interface and lysosomal dysfunction mechanisms.
• Represents a tractable target for CRISPR knockout, knock-in and overexpression studies.
• Serves as a model system for membrane trafficking, organelle identity and stress signaling.
What Happens During endoplasmic reticulum-Golgi intermediate compartment?
Cargo arrival from the ER
In simple terms: Proteins made in the ER are packaged into carriers that first stop at the ERGIC.
The ERGIC receives cargo from the ER and operates as a complex system of membrane-bounded compartments with a distinctive membrane protein composition. This step defines the compartment as the first intermediate between the ER and the Golgi and is the basis for its annotation as GO:0005793.
Sorting and concentration
In simple terms: The ERGIC acts like a post office that sorts packages before they move on.
Within the ERGIC, cargo is sorted and concentrated before onward delivery, and the compartment is characterized by marker proteins such as LMAN1 (ERGIC-53) that are used to identify it experimentally. Binding assays for ERGIC-53/LMAN1 have been developed to probe its interactions and function.
ER-to-Golgi and Golgi-to-ER transport
In simple terms: Traffic moves in both directions through the ERGIC, not just forward.
The ERGIC mediates both ER-to-Golgi and Golgi-to-ER transport, making it a bidirectional hub rather than a one-way conveyor. This dual role is central to the QuickGO definition of GO:0005793.
Signaling and autophagy
In simple terms: The ERGIC is also a signal relay station, not only a traffic junction.
STING trafficking through the ERGIC is required for autophagy induction, identifying the compartment as a signaling platform downstream of cGAS. This expands the functional scope of GO:0005793 beyond canonical membrane traffic.
Stress and disease-associated signaling
In simple terms: When the ERGIC is perturbed, stress pathways can be activated.
ERGIC-3 knockdown suppresses lung cancer through ER stress-induced autophagy, showing that ERGIC components can drive stress-dependent phenotypes. Disease-associated factors at the ER-Golgi interface further link this compartment to human pathology.
Key Genes Involved in GO:0005793 endoplasmic reticulum-Golgi intermediate compartment
The following genes and proteins are experimentally associated with the ERGIC and are commonly used to study GO:0005793.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LMAN1 (ERGIC-53) | ERGIC-resident cargo receptor | Widely used ERGIC marker; binding assays available |
| ERGIC-53 | Alternative name for LMAN1 | Marker for ERGIC identification |
| ERGIC-3 | ERGIC-associated membrane protein | Knockdown suppresses lung cancer via ER stress-induced autophagy |
| STING | Signaling adaptor trafficking through ERGIC | Required for autophagy induction downstream of cGAS |
| cGAS | Cytosolic DNA sensor upstream of STING | Defines the cGAS-STING-ERGIC autophagy axis |
| APOE | Lipid transport protein | APOE4-associated lysosomal dysfunction involves ER-Golgi mechanisms |
| COPI components | Retrograde Golgi-to-ER carriers | Function at the ER-Golgi interface |
| COPII components | Anterograde ER-to-Golgi carriers | Function at the ER-Golgi interface |
| RAB1 | Small GTPase in ER-Golgi traffic | Regulates intermediate compartment dynamics |
| RAB2 | Small GTPase in ER-Golgi traffic | Regulates intermediate compartment dynamics |
| SNARE proteins | Membrane fusion machinery | Mediate ERGIC membrane fusion events |
| ERGIC membrane proteins | Distinctive compartment markers | Define ERGIC identity by composition |
| Plant ERGIC proteins | Plant homologs of ERGIC machinery | Emerging model for ERGIC biology |
| Disease-associated ER-Golgi factors | Interface proteins linked to disease | Candidate targets in cancer and neurodegeneration |
| Lysosomal proteins | Proteomic readout of ER-Golgi dysfunction | Reveal mechanisms in APOE4 neurons |
How Is endoplasmic reticulum-Golgi intermediate compartment Regulated?
ERGIC function is regulated at the level of membrane traffic and signaling. The compartment mediates bidirectional ER-to-Golgi and Golgi-to-ER transport, and its distinctive membrane protein composition is maintained by sorting and retrieval mechanisms. Signaling through STING requires transit through the ERGIC to induce autophagy, providing a regulated link between innate immunity and this compartment. In cancer cells, ERGIC-3 levels influence ER stress-induced autophagy, indicating that ERGIC components can modulate stress-responsive programs. Disease-associated factors at the ER-Golgi interface further suggest that regulation of this compartment is relevant to pathological states.
endoplasmic reticulum-Golgi intermediate compartment and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ERGIC-3 | Lung cancer suppression via ER stress-induced autophagy | CRISPR knockout in lung cancer cell lines |
| STING | Innate immunity and autophagy induction | Knockout and tagged knock-in for trafficking assays |
| APOE | APOE4-associated neuronal lysosomal dysfunction | Knock-in of APOE4 in neuronal models |
| LMAN1 (ERGIC-53) | ERGIC marker and cargo receptor biology | Tagged knock-in and binding assays |
| ER-Golgi interface factors | Disease-associated ER-Golgi dysfunction | CRISPR perturbation and proteomics |
Cancer
ERGIC-3 knockdown suppresses lung cancer through endoplasmic reticulum stress-induced autophagy, demonstrating that an ERGIC component can act as a functional driver of tumor phenotypes. This places GO:0005793 within cancer cell biology and suggests ERGIC proteins as candidate targets for mechanistic studies.
Neurodegeneration and lysosomal dysfunction
Lysosomal proteomics has revealed mechanisms of neuronal APOE4-associated lysosomal dysfunction, implicating ER-Golgi interface processes in neurodegeneration. Disease-associated factors at the ER-Golgi interface further connect this compartment to neurological disease mechanisms.
Innate immunity and autophagy
STING trafficking through the ERGIC is required for autophagy induction via the cGAS pathway, linking GO:0005793 to innate immune signaling. This makes the ERGIC relevant to host defense and autophagy-related disease contexts.
From endoplasmic reticulum-Golgi intermediate compartment-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is an ERGIC gene required for cargo transport? | CRISPR knockout cell line |
| Does a disease variant alter ERGIC function? | Point-mutation knock-in |
| Where does a protein localize within the ERGIC? | Tagged knock-in with fluorescent tag |
| Does overexpression of an ERGIC protein change stress responses? | Overexpression cell model |
| Does STING trafficking through the ERGIC control autophagy? | Knockout and tagged knock-in of STING |
| Do ER-Golgi interface changes alter lysosomal function? | APOE4 knock-in neuronal model |
How to Study the endoplasmic reticulum-Golgi intermediate compartment Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence imaging with ERGIC markers | Localization and morphology of the compartment | Identifying ERGIC in cells |
| Binding assay for ERGIC-53/LMAN1 | Protein interactions of the marker | Validating ERGIC protein function |
| Proteomics | Protein composition of compartments | Lysosomal and ER-Golgi studies |
| Autophagy assays | Autophagic flux and induction | Testing STING-ERGIC signaling |
| Knockdown/knockout | Loss-of-function phenotypes | Testing ERGIC-3 in cancer |
| ER stress assays | Stress pathway activation | Linking ERGIC to autophagy |
| Disease variant modeling | Effect of disease-associated alleles | ER-Golgi interface disease studies |
| Plant ERGIC analysis | ERGIC organization in plants | Comparative ERGIC biology |
Imaging and organelle markers
Because the ERGIC is defined by a distinctive membrane protein composition, imaging with markers such as LMAN1 (ERGIC-53) is a standard approach to identify and track the compartment. Binding assays for ERGIC-53/LMAN1 support biochemical validation of marker behavior.
Proteomics
Proteomic profiling of lysosomes and related compartments has been used to reveal mechanisms of neuronal APOE4-associated lysosomal dysfunction, providing a template for studying ER-Golgi interface contributions. Such approaches can identify disease-associated factors at the ER-Golgi interface.
Functional perturbation
Knockdown of ERGIC-3 suppresses lung cancer through ER stress-induced autophagy, illustrating how loss-of-function experiments can define ERGIC gene function. CRISPR-based perturbation extends this logic to precise genetic models.
Signaling assays
STING trafficking through the ERGIC can be interrogated with autophagy and innate immune readouts to test the cGAS-STING-ERGIC axis. These assays connect GO:0005793 to signaling outcomes.
How CRISPR Can Be Used to Study GO:0005793 endoplasmic reticulum-Golgi intermediate compartment
Knockout
CRISPR knockout of ERGIC genes such as ERGIC-3 can test whether the compartment is required for phenotypes like ER stress-induced autophagy and cancer cell suppression. Knockout of STING can similarly test its ERGIC-dependent role in autophagy induction.
Point Mutation
Point-mutation knock-in can model disease-associated variants at the ER-Golgi interface and determine whether specific residues alter ERGIC function. This approach is suited to testing causal effects of individual alleles.
Knock-in
Tagged knock-in of ERGIC markers such as LMAN1 (ERGIC-53) enables visualization and biochemical isolation of the compartment in its native context. Knock-in of APOE4 supports studies of ER-Golgi-related lysosomal dysfunction.
Overexpression
Overexpression of ERGIC components can test gain-of-function effects on trafficking, stress responses and autophagy. It complements loss-of-function models to establish causality.
How EDITGENE Supports endoplasmic reticulum-Golgi intermediate compartment Research
Researchers studying endoplasmic reticulum-Golgi intermediate compartment-related genes often need to determine whether a candidate gene is causally involved in ERGIC function, cargo transport or disease-associated stress responses. EDITGENE provides CRISPR-based cell models and screening services that allow such hypotheses to be tested directly in human cells.
Contact EDITGENE today to design your custom CRISPR model for endoplasmic reticulum-Golgi intermediate compartment research.
Frequently Asked Questions About endoplasmic reticulum-Golgi intermediate compartment
What is the endoplasmic reticulum-Golgi intermediate compartment (GO:0005793)?
It is a complex system of membrane-bounded compartments located between the ER and the Golgi complex, with a distinctive membrane protein composition, involved in ER-to-Golgi and Golgi-to-ER transport.
What genes are involved in the endoplasmic reticulum-Golgi intermediate compartment?
Key experimentally associated genes include LMAN1 (ERGIC-53), ERGIC-3, STING and cGAS, among others.
What is another name for the ERGIC?
Synonyms include ER-Golgi intermediate compartment, pre-Golgi intermediate compartment, vesicular-tubular cluster (VTC), ER-Golgi transport container and EGTC.
What is the function of the ERGIC?
It mediates ER-to-Golgi and Golgi-to-ER transport and sorts cargo between the ER and the Golgi complex.
Is the ERGIC involved in autophagy?
Yes, STING trafficking through the ERGIC is required for autophagy induction via the cGAS pathway.
How is ERGIC-53 used in research?
ERGIC-53 (LMAN1) is a widely used ERGIC marker, and binding assays have been developed to study it.
What diseases are linked to the ERGIC?
ERGIC-3 has been linked to lung cancer suppression via ER stress-induced autophagy, and ER-Golgi interface factors are linked to neurodegeneration and lysosomal dysfunction.
How do you study the ERGIC in the lab?
Common approaches include imaging with ERGIC markers, proteomics, autophagy assays and CRISPR-based perturbation.
Can CRISPR be used to study ERGIC genes?
Yes, knockout, point-mutation, knock-in and overexpression models can test ERGIC gene function.
Is the ERGIC studied in plants?
Yes, recent work has begun to unravel the ERGIC in plant cells, extending comparative ERGIC biology.
Conclusion
GO:0005793 defines the endoplasmic reticulum-Golgi intermediate compartment as a bidirectional sorting station with a distinctive membrane protein composition that mediates ER-to-Golgi and Golgi-to-ER transport. Beyond canonical trafficking, the ERGIC functions as a signaling platform for STING-dependent autophagy and is connected to cancer, neurodegeneration and lysosomal dysfunction through ER-Golgi interface factors. CRISPR-based knockout, knock-in, point-mutation and overexpression models provide direct ways to test the causal roles of ERGIC genes in these processes.
References
- 1. Gui X et al.. 2019. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway.. Nature 567(7747):262-266 PMID: 30842662
- 3. Nishihara S et al.. 2021. Expression and binding assay of endoplasmic reticulum-Golgi intermediate compartment protein 53 (ERGIC-53, LMAN1).. PMID: 37590728
- 4. Unknown. 2025. Unravelling the endoplasmic reticulum-Golgi intermediate compartment in plant cells.. Nat Cell Biol 27(3):382-383 PMID: 40044904
- 5. Hauri HP et al.. 1992. The endoplasmic reticulum-Golgi intermediate compartment.. Curr Opin Cell Biol 4(4):600-8 PMID: 1419041
- 6. Maeda M et al.. 2025. Disease-Associated Factors at the Endoplasmic Reticulum-Golgi Interface.. Traffic 26(1-3):e70001 PMID: 40047103
- 7. Hong SH et al.. 2016. Endoplasmic reticulum-Golgi intermediate compartment protein 3 knockdown suppresses lung cancer through endoplasmic reticulum stress-induced autophagy.. Oncotarget 7(40):65335-65347 PMID: 27588471
- 8. Krogsaeter EK et al.. 2025. Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction.. Autophagy 21(12):3240-3265 PMID: 41103078
